BACKGROUND: Research examining the relationship between adiponectin (AN) isoforms, body weight and cardiovascular (CV) risk factors is limited, particularly in younger populations. OBJECTIVES: To investigate the inter-relationships between AN isoforms and CV risk factors, and their dependence on body weight status, in adolescents. DESIGN: Blood samples from 92 obese, 92 overweight and 92 normal weight age-and sex-matched adolescents were analysed for traditional cardiovascular disease (CVD) risk biomarkers and also total, high molecular weight (HMW), medium and low molecular weight (LMW) AN. RESULTS: A significant inverse association was observed between total and HMW AN and waist-hip ratio (P ¼ 0.015, P ¼ 0.006, respectively), triglycerides (P ¼ 0.003, P ¼ 0.003, respectively) and systolic blood pressure (P ¼ 0.012, P ¼ 0.024, respectively) and a significant positive association with high-density lipoprotein (Po0.001, Po0.001, respectively) in multi-adjusted analyses. There was no evidence of a relationship between multimeric AN and high-sensitivity C-reactive protein. There was also little evidence of a relationship between LMW AN and CVD risk factors. There was a strong, body mass index (BMI)-independent, association between AN, CVD biomarkers and the hypertriglyceridemic waist phenotype. CONCLUSION: Prominent, BMI-independent associations between total and HMW AN, but not LMW AN, and CVD risk factors were already evident in this young population. This research in adolescents supports the contention that AN subfractions may have different biological actions. These associations in apparently healthy adolescents suggest an important role for AN and its subfractions in the pathogenesis of metabolic syndrome traits and indicate that the potential for total or HMW AN to act as early universal biomarkers of CV risk warrants further study.
INTRODUCTION
Adipose tissue can no longer be regarded solely as a passive energy depot but rather it serves as a major endocrine organ 1 that secretes a variety of proteins, called adipokines; these adipokines have para-and endocrine actions. 2 Adiponectin (AN) is one such adipokine whose expression is reduced in overweight/obese states 3 and increases with subsequent weight reduction in prospective studies in adults 4, 5 and children/adolescents. 6, 7 Clinical studies have implicated hypoadiponectinemia in the pathogenesis of type 2 diabetes 8 and coronary artery disease (CAD). 9 The protective role of AN in the development of cardiovascular disease (CVD) in adults is thought to be mediated through the inverse associations between AN and adiposity, 10 low-density lipoproteins, 11, 12 triglycerides 10, 12 and blood pressure 13, 14 and the positive association with high-density lipoproteins (HDL). 4, 11 AN circulates in three isoforms; a trimer (low molecular weight (LMW)), a hexamer of medium-molecular-weight (MMW) and a larger multimeric high-molecular-weight (HMW) isoform. 10 Mechanisms that regulate the formation and distribution of the different multimeric forms of AN remain poorly known to date, but it has been suggested that the HMW form of AN is predominantly responsible for its biological effects in liver, muscle and endothelial tissues. 15 Studies examining the multimeric forms of AN in relation to traditional and non-traditional risk factors for CVD remain relatively low in number compared with those examining total AN only. Studies of AN isoforms have mainly demonstrated that the HMW form is the most metabolically active, 4, 16, 17 compared with the MMW and LMW forms, and that HMW AN is a better marker of insulin resistance and CVD risk than total AN. [17] [18] [19] Recent research 20 suggests that individuals with low levels of HMW and MMW AN and concurrent hypercholesterolaemia are more susceptible to sequential CVD. Most of the research regarding the relationship between AN, obesity and cardiovascular (CV) risk comes from adult populations. 21, 22 However, as body weight tracks into adulthood, and fat stores are likely to persist and expand with age, these relationships warrant investigation in younger age groups. Assessment of total 1 AN, or specific multimers of AN, as a global indicator of cardiometabolic health, may offer an opportunity to identify young people who are most at risk and so most likely to benefit from preventive intervention. To date, only two studies have simultaneously explored the relationship between the three AN isoforms and CVD risk biomarkers in the early stages of obesity; 23, 24 most of the limited research regarding multimeric AN and CV risk in young populations has only measured one isoform. 25, 26 The aim of this study was to examine the interrelationships between the different isoforms of AN and CV risk factors, and their dependence on weight status, in an adolescent population.
MATERIALS AND METHODS

Study population
The Young Hearts (YH) 2000 project was the second in a series of large cross-sectional epidemiological studies performed in a representative sample of Northern Irish adolescents. The YH's Project was originally designed to examine CVD risk factors in adolescents. Potential eligibility was determined by calculating age on the first day of testing in the school (that is, aged 12 or 15 years old on the first day of testing). Eligible participants were selected using a computer-generated random number list and groups were formed according to age and gender. This resulted in B500 participants in each of the four age/sex groups, that is, 12-year-old boys, 12-year-old girls, 15-year-old boys and 15-year-old girls. There were a total of 2017 participants in the YH2000 project consisting of 12 and 15 year olds from 36 nationally representative schools (response rate ¼ 65.4%). Detailed methodology has been described elsewhere. 27 The main aim was to identify the prevalence of CVD risk factors in adolescents (aged between 12 and 15 years) and the research was conducted between 1999 and 2001. YH2000 participants were categorised as obese, overweight or normal weight based on age-and sex-specific cutoff points for body mass index (BMI) using data specific centiles linked to adult cutoff points, as defined by Cole et al. 28 Overweight and obesity had a prevalence of 16.2% (n ¼ 327) and 4.7% (n ¼ 95), respectively. Obese children (n ¼ 95) were selected and matched according to age (age was defined as years of age ± 6 months, for example, a 12-year-old child ranged from 11.5-12.5 years), sex and smoking status (current, previous and never) with overweight and normal weight children. Blood samples could not be obtained from 3 of the obese adolescents so the final participants were reduced to 92 in each of the three groups (n ¼ 276). Full details of the study protocols have been described elsewhere 29, 30 but are explained in brief below. Ethical approval was obtained from the Medical Research Ethical Committee of Queen's University Belfast and written informed consent was obtained from both the parents and adolescents.
Measurements and surveys
Standing height and body weight were measured using standardised protocols and used to calculate BMI. Smoking status was evaluated by confidential self-report questionnaire; participants classified themselves as a smoker (reporting the quantity of cigarettes smoked per week), nonsmoker or former smoker. Percentage body fat was calculated from data obtained from skin-fold measurements at four sites: triceps, biceps, subscapular and suprailiac. Pubertal status was assessed by a paediatrician using visual signs, such as non-genital secondary hair growth, vocal timbre, body habitus, general muscular development and overall breast development in girls and was classified according to Tanner stages. 31 Blood pressure was measured twice from the right arm using a Hawksley random zero sphygmomanometer, after at least a 5-min rest. Measurements were recorded to the nearest 2 mm Hg and were performed by a paediatrician. Waist and hip measurements were recorded to the nearest 0.1 cm using a non-stretch tape measure and were used to calculate waist to hip ratio.
Laboratory analysis
Non-fasting peripheral venous blood (B16 ml) was obtained at 1000 hours by venipuncture and collected into serum z clot activator, EDTA-sodium and lithium heparin coated tubes. Serum/plasma was removed following centrifugation at 1100 g for 10 min at 4 1C within 4 h from venipuncture and stored at À 70 1C until required for analysis.
Total cholesterol, HDL and triglycerides were determined using enzymatic assays (Boehringer, Mannheim, Germany) on a Cobas Fara automated analyser according to the World Health Organisation (WHO) standards of quality control. Plasma high-sensitivity C-reactive protein (hs-CRP) was quantified by a high-sensitivity latex-enhanced immunoturbidimetric assay (Wako Chemicals GmbH, Neuss, Germany) using a Cobas Fara automated analyser (Roche Diagnostics, Burgess Hill, West Sussex, UK). The intra-assay and inter-assay coefficient of variations were o5%. The different multimeric forms of plasma AN were determined using commercially available sandwich enzyme-linked immunosorbent assays (ELISA) (ALPCO Diagnostics, Salem, NH, USA) according to the manufacturer's instructions. Total AN and HMW AN were measured directly from the assay plates, whereas MMW and LMW AN were calculated; MMW was obtained by subtracting the concentration of HMW AN from the combined concentration of MMW and HMW (measured directly) and LMW was obtained by subtracting the combined concentration of MMW and HMW (measured directly) from the total concentration of AN. Mean inter-assay coefficient of variations for total AN, high AN and high-medium AN were 2.55%, 1.56% and 1.98%, respectively. For all laboratory procedures, the operator was blinded for sample classification.
Hypertriglyceridemic waist (HW) phenotype classification
In order to allow additional exploration of the relationship between AN and localisation of body fat, the HW phenotype was calculated. The HW phenotype was developed by Lemieux et al. 32 as a means of helping to identify individuals with intra-abdominal obesity, and associated metabolic abnormalities, who have an increased risk of CAD. For this YH2000 sample, HW phenotype was calculated based on a two-point scoring system used by Esmaillzadeh et al. 33 to classify adolescents as being at increased metabolic risk. As described in their manuscript, participants with a waist circumference (WC) value X90th percentile for age and sex within the sample population (n ¼ 3036 adolescents, 1413 males and 123 female within a prospective study performed in a representative sample of adolescents in a district of Tehran) were classified as having an enlarged WC. Between the age ranges of 10-19 years, a borderline high range for triglyceride concentration was given as 1.02-1.46 mmol l À 1 , the midpoint being 1.24 mmol l À 1 , which was taken as the 90th percentile value for age. Participants were then categorised into four phenotype groups on the basis of the mentioned cutoffs (Group 1, normal WC, normal triglyceride; Group 2, normal WC, elevated triglyceride; Group 3, enlarged WC and normal triglycerides; Group 4, enlarged WC and elevated triglycerides).
Statistics
All statistical analyses were carried out using SPSS version 17 for Windows (SPSS Inc, Chicago, IL, USA). Pearson's correlation coefficient was used to assess the relationship between all forms of AN and CVD risk factors (namely hs-CRP, total cholesterol, HDL, triglycerides, BMI, WC, waist-hip ratio (WHR), systolic blood pressure (SBP) and diastolic blood pressure (DBP)). Scatter diagrams of AN and the reported exposures were checked for approximate linearity before the calculation of correlation coefficients. Differences in AN concentrations in relation to weight status were examined using univariate analysis and test for linear trend. Linear regression was used to compare the mean concentration of a number of CVD risk factors between the different multimeric forms of AN. Multiple linear regression models were then used to compare the mean CVD risk factors between the different multimeric forms of AN while adjusting for potential confounders (age, sex, pubertal status and BMI). Univariate analysis was performed to assess the relationship between the HW phenotype and AN (all forms), using Bonferroni t-test for unadjusted and adjusted (age, sex and pubertal status) models.
RESULTS
Anthropometric characteristics
Participants were matched for age, sex and smoking status within the three weight categories (normal, overweight and obese). Weight, BMI, body fat percentage and WHR were significantly different across the three groups (Po0.001). Mean (s.d.) age of the sample for males and females was 13.6 (1.4) and 13.8 (1.5) years, respectively. There were no statistically significant differences in the multimeric forms of AN between males and females in the sample as a whole or when examined according to the three weight categories (normal weight, overweight and obese). Mean (s.d.) concentration of AN isoforms (mg ml À 1 ) for all males and all females, respectively: total AN 8.5 (3.2) and 9.0 (3.2), P ¼ 0. 
.001) and positively correlated with HDL (r ¼ 0.4, Po0.001).
MMW was negatively correlated with triglycerides (r ¼ À 0.1, AN, CVD risk markers and body weight status Table 1 shows the mean concentrations of AN (all multimeric forms and ratios) and a number of individual CVD risk factors according to BMI status. As expected, in the univariate analysis, a significant inverse association was observed between AN (total, HMW and MMW but not LMW) and BMI. For instance, Table 1 shows that: the mean total AN (ng ml À 1 ) was 10.1 in the normal, 9.1 in the overweight and 7.2 in the obese; there is evidence that the means in the three groups are not identical (analysis of variance Po0.001); and there is evidence that the mean reduces as weight increase (P for trend o0.001). The ratio between HMW and total AN was significantly decreased in the obese group, whereas the LMW/total AN ratio was significantly increased. An inverse association was also observed between BMI and HDL cholesterol. There was a significant positive association between body weight and triglycerides, SBP, DBP and hs-CRP.
Relationship between the different multimeric forms of AN and CVD risk markers Multiple linear regression analysis was conducted in order to examine the relationship between the individual forms of AN and the individual CV risk factors, these results are displayed in Table 2 (for total AN), Table 3 (for HMW AN), Table 4 (for MMW AN) and Table 5 (for LMW AN). For both total and HMW AN, a significant positive relationship was apparent with HDL; specifically, per mmol l À 1 increase in HDL cholesterol, total and HMW AN increased by on average 2.8 and 1.9 mg ml À 1 , respectively, after adjustment for age, sex, pubertal status and BMI (Po0.001). In adjusted analyses, both total and HMW AN showed a significant negative relationship with triglycerides, WHR and SBP. For example, for triglycerides, per mmol l À 1 increase in triglycerides, total and HMW AN decreased by, on average, 1.2 and 1.0 mg ml À 1 , respectively, (after full adjustments). Total and HMW AN were also inversely associated with hs-CRP and DBP after adjustment for age, sex and pubertal status but these relationships disappeared after further adjustment for BMI. Fewer associations were evident between MMW AN and CVD markers (Table 4) , however, the relationship between HDL and AN was also apparent for the MMW form; MMW AN increased by on average 0.8 mg ml À 1 per mmol l À 1 increase in HDL cholesterol, after adjustment for age, sex, pubertal status and BMI. MMW AN was not significantly associated with hs-CRP in unadjusted or adjusted analyses. There was a significant inverse association between MMW AN and triglycerides after adjustment for age, sex and pubertal status (P ¼ 0.023) but this relationship was attenuated after adjustment for BMI (P ¼ 0.356). As shown in Table 5 , there were no associations between LMW AN and markers of CV risk when full adjustments were applied.
Relationship between HW phenotype and AN (all forms) The prevalence of the HW phenotype (high WC, high triglycerides) was 6.2% in this cohort of Northern Irish adolescents. Mean total AN and HMW AN concentrations differed significantly (Po0.001) between the four groups of HW phenotype (Table 6 ). On investigation of the post hoc tests using Bonferroni's correction, group 1 (normal WC and normal serum triglycerides) had the highest total and HMW AN and was significantly different from group 3 (high WC and normal triglycerides) and group 4 (high WC and high triglycerides). No other significant differences were seen between the groups for total, HMW, MMW or LMW AN. After adjustment for age, sex and pubertal status the same relationships existed.
DISCUSSION
This research has uniquely examined all AN isomers in relation to CV risk factors in multi-adjusted analyses in adolescents who are Obese adolescents (n ¼ 92) from YH2000 were selected and matched according to age, sex and smoking status with overweight (n ¼ 92) and normal weight (n ¼ 92) adolescents, total n ¼ 276.
b P-value from ANOVA. c Linear regression with characteristics as the outcome and weight category as a continuous variable.
Adiponectin and cardiovascular risk in adolescents HJ McCourt et al normal weight, overweight or obese and thus adds significantly to the limited evidence that is currently available regarding the metabolic correlates of AN isoforms in the early stages of obesity and atherosclerosis. Specifically, this research revealed that multimer-specific relationships with CV risk factors are apparent even in adolescence; total and HMW AN were negatively correlated with triglyceride levels, WHR and SBP and strongly positively correlated with HDL cholesterol, and these associations were independent of BMI. Total and HMW were also significantly associated with the HW phenotype, which is indicative of increased risk of CAD. Unlike studies in adults, there was no evidence of a BMI-independent inverse association between AN multimers (any form) and hs-CRP levels in adolescents. This has also been noted by others [34] [35] [36] and may be reflective of the early pathophysiological environment. The associations apparent for total and HMW AN and CV risk markers were similar in this young population, whereas evidence from adult populations has generally indicated that the HMW form is a better marker of insulin resistance and CVD risk than total AN. [17] [18] [19] Within this cohort of adolescents, total, HMW and MMW, but not LMW, AN were inversely associated with BMI which is consistent with the adult literature 10, 19, 37 and studies in younger populations. 23, 38 Also consistent with previous observations in older and younger age groups, the ratio of HMW to total AN significantly decreased in obese adolescents, whereas the ratio of LMW to total AN significantly increased which may indicate a disturbed oligomerisation process from LMW to HMW AN. 24 Studies in adults indicate that the AN subfractions may have different biological functions, with HMW AN being the most metabolically active and most closely associated with risk of CVD. To date, only two studies have examined all AN isomers in relation to CV risk factor status in children or adolescents 23, 24 with a few other studies examining one specific isoform, mainly HMW AN. These studies tend to suggest that the HMW form of AN is closely associated with obesity and CVD biomarkers. Araki et al. 23 previously reported that HMW AN better reflected early metabolic abnormalities in childhood obesity (age range 5-15 years) compared with other forms, based on a strong association with visceral adipose tissue area, and also that plasma isoprostane concentration was inversely correlated with HMW but not total, MMW or LMW AN in obese children (age range 5-14 years). 39 In the former study, Araki et al. 23 also reported significant correlations between both total and HMW AN and triglycerides and homeostatic model assessment (HOMA), but only total AN 24 likewise examined all three isoforms of AN in 10-19 year olds and found that HMW AN had a better correlation with intima-media thickness compared with total AN, and that nuchal thickness of subcutaneous adipose tissue was associated with an increased LMW to total AN ratio. 36 They also noted, in an analysis only adjusted for gender, 24 that total and HMW AN were significantly positively correlated with HDL cholesterol and serum apolipoprotein a1, and significantly negatively correlated with BMI, HOMA and carotid intima-media thickness. Only HMW was significantly negatively correlated with trigylcerides after adjustment for gender. Murdolo et al. 25 focused on HMW AN in prepubertal children aged 5-13 years and reported that HMW correlated with insulin resistance measures, triglycerides and soluble intercellular adhesion molecule. Nakatani et al., 26 also focused on HMW AN in a sample of males aged 16-17 years old. They found that HMW AN was negatively correlated with BMI and WC, but not with HOMA or other metabolic parameters except HDL. This somewhat limited research in young populations does, therefore, provide some support for the metabolic prominence of HMW AN, although this is by no means proven at this stage as few studies have simultaneously assessed all AN isoforms.
Data concerning the physiological role of LMW AN remains extremely rare, particularly in juvenile populations, and findings are inconsistent. LMW AN has been negatively correlated with WC, BMI and WHR in some studies [40] [41] [42] but this relationship is inconsistent in adults 20, 37, 43 and generally absent in younger age groups. 23, 24 In relation to LMW AN and other CVD biomarkers, Baumann et al. 13 examined AN in relation to blood pressure and reported that whilst total AN was not significantly different between hypertensive and normotensive patients, there was a shift in isoform distribution, with HMW AN being significantly lower and LMW AN being significantly higher, in hypertensives versus normotensives. In contrast to this, Rizza et al. 12 recently reported that LMW AN appeared to exert a protective effect in older people who had CAD; LMW AN was the only multimeric form of AN not to be correlated with brain natriuretic peptide, which is associated with a more severe CV outcome.
As hypoadiponectinaemia is associated with dyslipidaemia, hypertension, insulin resistance, metabolic syndrome and type 2 diabetes, it has been proposed as a possible universal biomarker for cardiometabolic risk. 44 As previously discussed by Murdolo et al., 25 current conventional metabolic and CVD risk factors may not be sensitive enough to detect high-risk individuals in young Hypoadiponectinaemia has been shown to be predictive of development of metabolic syndrome in younger cohorts 45 and, furthermore, a high AN has been shown to be associated with a healthy obese phenotype in obese adolescents 46 and this phenotype appears to be protective against metabolic syndrome and its components after 7-year follow-up. 46 There is a discussion about whether assessment of total or HMW AN would be more appropriate in terms of disease risk-assessment. Some, but by no means all, research in adults and juveniles indicates that HMW may be a better marker of metabolic health than total AN. However, we observed a consistent relationship between both total and HMW AN for a range of CVD biomarkers and AlmedaValdes et al., 47 recently reported that total and HMW AN had similar utility for identification of insulin resistance and metabolic disturbances therefore suggesting that plasma total AN, which is cheaper, better standardised and more accessible, may provide clinical information of the same diagnostic value as HMW AN. These findings are contrary to previous research, which has shown that HMW AN is the most active form for the identification of insulin resistance as it is selectively downregulated in insulin resistance states. 19, 48 However, studies that support this conclusion have limitations, which include small sample size 49 and include biased populations. 19 Further research will be necessary to deduce the utility of total versus HMW AN as biomarkers of metabolic health.
This analysis must be interpreted in the context of certain limitations. First, it is widely accepted that AN is negatively correlated with markers of insulin resistance. [50] [51] [52] However, as non-fasting blood samples were collected in this study, it was not possible to examine the relationship between AN and insulin resistance, nor to look at the AN isoforms in relation to the metabolic syndrome. Nevertheless, the YH2000 cohort represents a well-defined and phenotypically well-characterised group of healthy adolescents and the analyses were adjusted for a multitude of potential confounding factors, thus providing valuable data in terms of the metabolic significance of multimeric AN at this life stage. The study was also crosssectional in nature therefore can only suggest, rather than establish, causal associations between the variables that have been examined.
In conclusion, prominent, BMI-independent, associations between total and HMW AN, but not LMW AN, and CVD risk factors were already evident in this young population. Notably, total and HMW AN were inversely associated with WHR, triglycerides and SBP and positively associated with HDL in multi-adjusted analyses. There was no evidence of a relationship between the AN multimers and hs-CRP. This research in adolescents supports the contention that AN subfractions may have different biological actions but, unlike findings from studies in adults, it does not indicate that HMW AN is necessarily a better biomarker of CV health than total AN, as total and HMW AN were similarly associated with CVD risk markers and the HW phenotype in this young population. These findings from an adolescent population support a possible role for total AN as an early universal biomarker of CV risk. As conventional metabolic and CVD risk factors may not be sensitive enough to detect high-risk individuals in young populations, further research should explore if total or HMW AN can be used early in the life course to identify individuals who are most likely to benefit from preventive intervention. Obese adolescents (n ¼ 92) from YH2000 were selected and matched according to age, sex and smoking status with overweight (n ¼ 92) and normal weight (n ¼ 92) adolescents, total n ¼ 276.
2 P from ANOVA with paired tests based upon Bonferroni correction post hoc adjustments. Data presented as mean (s.d.) and P for the difference in the mean. Within a row, groups with the same superscript are not significantly different from each other (using a Bonferroni-corrected adjusted t-test), while groups with different superscripts are significantly different from each other. 3 Adjusted for age, sex and pubertal status.
